ESG and Retirement Plan Investing
Scholars and practitioners assess recent changes to ERISA regulations that allow greater choice in investing.
Patent Law Could Also Limit Mifepristone Access
Existing patents deter the marketing of more affordable generic drugs that could be used off-label for abortions.
Week in Review
Florida bans teaching about gender identity and sexual orientation, FAA updates its guidelines for space launch approvals, and more…
Improving Public Engagement in the Regulatory Process
Biden Administration seeks feedback from the public on how to expand participation in the regulatory process.
The Growth in Business Support for Regulation
Businesses in the United States are increasingly supporting regulation and regulators against judicial decisions curtailing agency authority.
FDA’s Role in Access to Reproductive Health Care
Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.
Bettering Behavioral Health
Scholars examine regulatory solutions for improving behavioral health care.
Week in Review
EPA proposes new vehicle emissions limits, the Fifth Circuit temporarily blocks abortion pill approval suspension, and more…
Swimming Upstream Amid Climate Change
Scholar discusses possible legal avenues to support salmon conservation during climate change.
Regulating to Improve Methadone Access
Scholars identify avenues to curb regulatory barriers to substitution therapy.
Regulators Propose Updates to Community Reinvestment Act Rules
Financial regulators propose new rules to expand and modernize law that targets inequities in bank lending.